Medical Prognosis InstituteMPI

A personalized medicines company in cancer

The assignment focused on funding advice as well as
elaborating a commercial strategy for the launch
of a personalised medicine diagnostic biomarker.



An e-health company focussing on welfare solutions

Work has included commercial support and
more importantly M&A support along with advice
in connection with the sale of the company to Danish IT company E.G. in early 2016.



A microbiome company developing novel therapeutics
and next generation probiotics.

Work in this case included strategic advice and identifying
commercial route-to-market as well as business development support.


Scandinavian Micro BiodevicesSMB logo

A world leading micro fluidic point of care diagnostic company focusing on the veterinary market.

Main focus points included fundraising and strategic M&A support.



Asiros is an R&D founded innovative nutraceutical company.

Work with Asiros included developing
a commercial strategy along with a go-to-market plan.



INSERO is a venture fund investing
in innovative companies in Denmark.

The assignment was a full due diligence process on a potential investment.



Keosys is medical imaging IT company
in clinical research and medical diagnosis.

Working with Keosys focused on market entry support to the Danish market.




Injector develops innovative safety syringes
and auto injectors for the pharmaceutical
and medical device industry.

Work has included divestiture and M&A support.


CytoVacCytoVac s

CytoVac develops cancer immunotherapy treatments.

We worked mainly in the areas of strategy development,
elaboration of business plan as well as fundraising support.



Meta-IQ is a biotech company
developing treatments against multiple sclerosis.

Working with Meta-IQ included strategy development and fundraising.



LiplasomeLiPlasome logo

LiPlasome Pharma has developed
a liposomal reformulation technology for cancer products.

The project included a strategic review as well as fundraising support.



Brainreader has developed an automated software to analyse MR brains scans to support in the diagnosis of Alzheimer’s disease and dementia.

The assignment included development of a commercial strategy along with practical product launch support.



Dripmate is an early stage medical device
development company with a new innovative drip counter
for hospital use.

The task in this case was commercial advice in connection with future product launch.